跳至主要内容
临床试验/NCT05528237
NCT05528237Enrolling By Invitation不适用

Advancing Cervical Cancer Screening Through Self-Sampling (ACCESS): A Pilot Study of HPV Self-sampling for Cervical Cancer Prevention in Washington State

University of Washington6 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2022年8月18日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
50
试验地点
6
主要终点
Proportion of eligible individuals who accept self-sampling kits

研究概览

简要总结

The objective of this study is to evaluate self-collection of vaginal samples for HPV testing as an alternative cervical cancer screening strategy for persons with HIV and/or limited access to care. Self-collection kits will be offered to persons who refuse a Pap smear or are overdue (>=6 months) for cervical cancer screening, with screening uptake recorded as a primary outcome. Kits will be offered in-clinic to individuals who refuse a Pap smear, and individuals overdue for screening will have the option to receive and return kits in the mail. The investigators will additionally administer a phone-based survey to evaluate knowledge about HPV and cervical cancer, barriers and facilitators to screening, and attitudes towards screening. Data from medical records will be abstracted to describe the clinical characteristics of the sample and measure receipt of follow-up procedures. Focus groups will be conducted with clinic administrators, staff, and HIV and women's health experts to evaluate clinic and provider barriers and facilitators to cervical cancer screening. The investigators hypothesize that HPV self-sampling will result in favorable patient-centered outcomes and could reduce disparities in access to screening.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
25 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age >=25 and <65 (individuals without diagnosed HIV) or >=30 years (individuals with diagnosed HIV)
  • Female sex at birth
  • Proficient in English or Spanish
  • Refused a Pap smear or are >=6 months overdue for cervical cancer screening

排除标准

  • Current pregnancy
  • Complete hysterectomy
  • History of cervical cancer
  • Unable to provide informed consent

结局指标

主要结局

Proportion of eligible individuals who accept self-sampling kits

时间窗: Baseline (during clinical and/or study recruitment encounter)

the proportion of eligible individuals due or overdue for screening who agree to collect a vaginal sample for HPV testing.

Confidence with self-collection

时间窗: Within 2 weeks of sample collection

Participants will use a 5-point Likert scale (strongly agree, agree, neutral, disagree, strongly disagree) to respond to the statement, "I am sure I got a good sample using the swab."

Ease of returning home kits

时间窗: Within 2 weeks of sample collection

Participants who collected a sample at home will use a 5-point Likert scale (strongly agree, agree, neutral, disagree, strongly disagree) to respond to the statement, "It was easy to return my sample (by mail or to the clinic)."

Proportion of eligible individuals who submit self-sampled specimens

时间窗: 3 weeks from enrollment

the proportion of individuals who agree to self-collection who return samples

Satisfaction with self-collection

时间窗: Within 2 weeks of sample collection

Participants will use a 5-point Likert scale (strongly agree, agree, neutral, disagree, strongly disagree) to respond to the statement, "I was satisfied with the self-collection experience."

Recommendation of self-collection

时间窗: Within 2 weeks of sample collection

Participants will use a 5-point Likert scale (strongly agree, agree, neutral, disagree, strongly disagree) to respond to the statement, "I would recommend self-collection to a friend."

次要结局

  • Proportion of eligible individuals who return samples with adequate specimens(3 weeks from enrollment)
  • Perceived risk of cervical cancer(Baseline)
  • Provider and/or clinic barriers and facilitators to cervical cancer screening survey(During study year 1)
  • Knowledge about HPV and cervical cancer screening(Baseline)
  • Reflex cytology results checklist(Up to 6 months after self-sampling)
  • HPV prevalence checklist(Baseline)
  • Attitudes and preferences for screening(Baseline)
  • Colposcopy results checklist(Up to 6 months after self-sampling)
  • Receipt of follow-up care(Up to 6 months after self-sampling)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Darcy W Rao, PhD

Acting Assistant Professor: School of Public Health

University of Washington

研究点 (6)

Loading locations...

相似试验